Correlation Between ChemoMetec and CBrain AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ChemoMetec and CBrain AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec and CBrain AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and cBrain AS, you can compare the effects of market volatilities on ChemoMetec and CBrain AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec with a short position of CBrain AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec and CBrain AS.

Diversification Opportunities for ChemoMetec and CBrain AS

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ChemoMetec and CBrain is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and cBrain AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on cBrain AS and ChemoMetec is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with CBrain AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of cBrain AS has no effect on the direction of ChemoMetec i.e., ChemoMetec and CBrain AS go up and down completely randomly.

Pair Corralation between ChemoMetec and CBrain AS

Assuming the 90 days trading horizon ChemoMetec AS is expected to generate 1.13 times more return on investment than CBrain AS. However, ChemoMetec is 1.13 times more volatile than cBrain AS. It trades about 0.05 of its potential returns per unit of risk. cBrain AS is currently generating about 0.01 per unit of risk. If you would invest  33,680  in ChemoMetec AS on March 25, 2025 and sell it today you would earn a total of  18,470  from holding ChemoMetec AS or generate 54.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ChemoMetec AS  vs.  cBrain AS

 Performance 
       Timeline  
ChemoMetec AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, ChemoMetec is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
cBrain AS 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in cBrain AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, CBrain AS sustained solid returns over the last few months and may actually be approaching a breakup point.

ChemoMetec and CBrain AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ChemoMetec and CBrain AS

The main advantage of trading using opposite ChemoMetec and CBrain AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec position performs unexpectedly, CBrain AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CBrain AS will offset losses from the drop in CBrain AS's long position.
The idea behind ChemoMetec AS and cBrain AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device